Find Faculty

Noura S Abul-Husn, MD, PhD

img_Noura S Abul-Husn
ASSOCIATE CLINICAL PROFESSOR | Medicine, Medical Genomics
Research Topics
Clinical Genomics, Genetics, Genomics
Multi-Disciplinary Training Area
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS]

MD, Icahn School of Medicine at Mount Sinai

PhD, Icahn School of Medicine at Mount Sinai

105
Publications

Selected Publications

Association of high and moderate penetrance monogenic variants, polygenic risk, and family history with breast cancer in an ancestrally diverse population. Emily R. Soper, Nicole A. Casasanta, Bethany Dubois, Gillian M. Belbin, Eimear E. Kenny, Noura S. Abul-Husn. Cancer genetics

Publisher Correction: Multi-ancestry genome-wide association analyses of refractive error augment genetic discovery and polygenic prediction (Nature Genetics, (2026), 58, 5, (1030-1039), 10.1038/s41588-026-02576-0). Fei Fei Cheng, Xiaoxi Liu, Hao Mi, Lizhong Wang, Ruilei Ma, Yazhou Guo, Julia Sidorenko, Chen Jiang, Tania Islam, Akira Meguro, Keiko Hikino, Yuki Ishikawa, Senwei Tang, Teng Li, Ruoyan Chen, Likun Wang, Reedik Mägi, Andres Metspalu, Georgi Hudjashov, Mari Nelis, Tõnu Esko, Lili Milani, William A. Freyman, Steven J. Micheletti, Peter R. Wilton, Jingran Wen, James R. Ashenhurst, G. David Poznik, Ethan M. Jewett, Éadaoin Harney, Chris German, Bertram L. Koelsch, Anna Guan, Aditya Ambati, Stacey B. Detweiler, Ruth I. Tennen, Rebecca M.K. Berns, R. Ryanne Wu, Noura S. Abul-Husn, Alisa P. Lehman, Wanwan Xu, Vinh Tran, Stella Aslibekyan, Shubham Saini, Sayantan Das, Robert K. Bell, Qiaojuan Jane Su, Matthew J. Kmiecik, Matthew H. McIntyre, Keng Han Lin. Nature Genetics

Genetic predictors of GLP1 receptor agonist weight loss and side effects. Qiaojuan Jane Su, James R. Ashenhurst, Wanwan Xu, Vinh Tran, R. Ryanne Wu, Catherine H. Weldon, Jingchunzi Shi, Barry Hicks, Joyce Y. Tung, Teague Sterling, Suyash Shringarpure, Anjali J. Shastri, Shubham Saini, Carrie Northover, Alex Moran, Matthew H. McIntyre, Keng Han Lin, Yanyu Liang, Alan Kwong, Matthew J. Kmiecik, Aly Khan, Reza Jabal, David A. Hinds, Larry Hengl, Julie M. Granka, Chris German, Shirin Fuller, Sarah L. Elson, Chris Eijsbouts, Emily DelloRusso, Payambr Dibaeinia, Devika Dhamija, Kahsaia de Brito, Sayantan Das, Zayn Cochinwala, Katelyn Kukar Bond, Robert K. Bell, Noura S. Abul-Husn, Stella Aslibekyan, Michael V. Holmes, Bertram L. Koelsch, Adam Auton. Nature

View All Publications

Population Genomic Health: Bridging Genomics into Clinical Care

Annenberg Building Floor 18 Room 80

1468 Madison Ave

New York, NY 10029

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Abul-Husn during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Inflection Medicine

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Inflection Medicine

Outside Employment

  • 23andMe Research Institute

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.